Faculty
Hematology Division
Alphabetical list (active faculty):   
Charles S. Eby

Charles S. Eby, MD

Professor

Department of Medicine

Hematology Division

Department of Pathology & Immunology

Clinical Interests

  • General hematology
  • Hemostasis & thrombosis

Research Interests

  • Pharmacogenomics of warfarin

Contact

  • 314-362-3186 (office)
  • Department of Pathology & Immunology
    Mail Stop 8118-0004-04
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 4th Floor BJC Institute of Health (office)

Peer-reviewed Manuscripts

  • Increasing Ferritin Predicts Early Death in Adult Hemophagocytic Lymphohistiocytosis
    Abou Shaar R, Eby CS, van Dorp S, de Witte T, Otrock ZK
    Int J Lab Hematol 2021 Oct;43(5):1024-1031
  • Multiplatform Assessment of Saliva for SARS-CoV-2 Molecular Detection in Symptomatic Healthcare Personnel and Patients Presenting to the Emergency Department
    Potter RF, Ransom EM, Wallace MA, Johnson C, Kwon JH, Babcock HM, Eby CS, Anderson NW, Parikh BA, Burnham CD
    J Appl Lab Med 2021 Sep 7; [Epub ahead of print]
  • Evaluation of PCR Cycle Threshold Values by Patient Population With the Quidel Lyra SARS-CoV-2 Assay
    Potter RF, Abro B, Eby CS, Burnham CD, Anderson NW, Parikh BA
    Diagn Microbiol Infect Dis 2021 Oct;101(2):115387
  • Evaluation of a Patient With Extremely High Mean Corpuscular Hemoglobin and Mean Corpuscular Hemoglobin Concentration
    Tang MS, Wettach GR, Eby CS
    Clin Chem 2020 Mar 1;66(3):497-498
  • Electrolytes Gone Wild in a 56-Year-Old Man
    Tang MS, McCoy DG, Eby CS, Scott MG
    Clin Chem 2020 Feb 1;66(2):398-399
  • Association Between the HLA-DRB1*03:01-DQB1*02:01 Haplotype and PF4/Heparin Antibodies
    Zhang R, Duffy BF, Lange V, Eby CS, Liu C
    Blood Adv 2019 Oct 22;3(20):3136-3142
  • Effect of Low-Intensity Vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial
    Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V, Eby CS
    JAMA 2019 Sep 3;322(9):834-842
  • Plasmapheresis for Management of Antiphospholipid Syndrome in the Neurosurgical Patient
    Arias EJ, Bruck B, Vellimana AK, Eby C, Reynolds MR, Blinder MA, Zipfel GJ
    Oper Neurosurg (Hagerstown) 2019 Apr 1;16(4):E124-E129
  • Human Ehrlichiosis at a Tertiary-Care Academic Medical Center: Clinical Associations and Outcomes of Transplant Patients and Patients With Hemophagocytic Lymphohistiocytosis
    Otrock ZK, Eby CS, Burnham CD
    Blood Cells Mol Dis 2019 Jul;77:17-22
  • Blast Flagging of the Sysmex XN-10 Hematology Analyzer With Supervised Cell Image Analysis: Impact on Quality Parameters
    Petrone J, Jackups R Jr, Eby CS, Shimer G, Anderson J, Frater JL
    Int J Lab Hematol 2019 Oct;41(5):601-606
  • Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients
    Bass AR, Szymonifka JD, Rondina MT, Bogardus M, Scott MG, Woller SC, Stevens SM, Eby C, Merritt K, Valle AGD, Moskowitz G, Flores E, Gage BF
    HSS J 2018 Feb;14(1):67-76
  • Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA
    Carlson AL, Pastula DM, Lambert AJ, Staples JE, Muehlenbachs A, Turabelidze G, Eby CS, Keller J, Hess B, Buller RS, Storch GA, Byrnes K, Dehner L, Kirmani N, Kuhlmann FM
    Emerg Infect Dis 2018 May;24(5):893-897
  • Transfusion Requirements and 30-Day Mortality Predictors for Adult Hemophagocytic Lymphohistiocytosis
    Otrock ZK, Grossman BJ, Eby CS
    Int J Hematol 2018 Nov;108(5):485-490
  • Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial
    Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V, Eby CS
    JAMA 2017 Sep 26;318(12):1115-1124
  • Elevated Serum Ferritin Is Not Specific for Hemophagocytic Lymphohistiocytosis
    Otrock ZK, Hock KG, Riley SB, de Witte T, Eby CS, Scott MG
    Ann Hematol 2017 Oct;96(10):1667-1672
  • Commentary
    Eby CS
    Clin Chem 2017 Sep;63(9):1444-1445
  • Diagnostic Challenges of Hemophagocytic Lymphohistiocytosis
    Otrock ZK, Daver N, Eby CS
    Clin Lymphoma Myeloma Leuk 2017 Jul;17S:S105-S110
  • Safety and Collection Efficiency With a Lower Transfusion Threshold for Extracorporeal Photopheresis in Adult Patients With Graft-Versus-Host Disease
    Liu C, Schindler E, LeRoy M, Martin-Bredahl K, Dino M, Shah K, Dynis M, Eby CS, Grossman BJ
    Vox Sang 2017 May;112(4):379-387
  • Use of Signals and Systems Engineering to Improve the Safety of Warfarin Initiation
    Hyun G, Li J, Bass AR, Mohapatra A, Woller SC, Lin H, Eby C, McMillin GA, Gage BF
    J Thromb Thrombolysis 2016 Nov;42(4):529-33
  • Triangulating Dynamic of Clinical Laboratory Testing
    Weinert K, Gyorda P, Rifai N, Evans S, Kaufman HW, Eby CS, Ashwood ER, Moore N
    Clin Chem 2015 Nov;61(11):1320-7
  • Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
    Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM
    J Natl Compr Canc Netw 2015 Sep;13(9):1079-95
  • Ehrlichia-Induced Hemophagocytic Lymphohistiocytosis: A Case Series and Review of Literature
    Otrock ZK, Gonzalez MD, Eby CS
    Blood Cells Mol Dis 2015 Oct;55(3):191-193
  • Clinical Characteristics, Prognostic Factors, and Outcomes of Adult Patients With Hemophagocytic Lymphohistiocytosis
    Otrock ZK, Eby CS
    Am J Hematol 2015 Mar;90(3):220-4
  • A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer
    Roop RP, Naughton MJ, Van Poznak C, Schneider JG, Lammers PE, Pluard TJ, Johnson F, Eby CS, Weilbaecher KN
    Clin Breast Cancer 2013 Dec;13(6):409-15
  • A Pharmacogenetic Versus a Clinical Algorithm for Warfarin Dosing
    Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH
    N Engl J Med 2013 Dec 12;369(24):2283-93
  • Venous Thromboembolic Disease
    Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogerty AE, Gao S, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Siddiqi T, Smith JL, Yee GC, Zakarija A, McMillian N, Naganuma M
    J Natl Compr Canc Netw 2013 Nov;11(11):1402-29
  • Rationale and Design of the Clarification of Optimal Anticoagulation Through Genetics Trial
    Kimmel SE, French B, Anderson JL, Gage BF, Johnson JA, Rosenberg YD, Geller NL, Kasner SE, Eby CS, Joo J, Caldwell MD, Goldhaber SZ, Hart RG, Cifelli D, Madigan R, Brensinger CM, Goldberg S, Califf RM, Ellenberg JH
    Am Heart J 2013 Sep;166(3):435-41
  • D-Dimer: Simple Test, Tough Problems
    Olson JD, Cunningham MT, Higgins RA, Eby CS, Brandt JT
    Arch Pathol Lab Med 2013 Aug;137(8):1030-8
  • Novel Anticoagulants and Laboratory Testing
    Eby C
    Int J Lab Hematol 2013 Jun;35(3):262-8
  • Warfarin Replacements: Good for Patients, Challenging for Laboratories
    Eby CS
    Clin Chem 2013 May;59(5):732-4
  • Linear Relationship Between Lymphocyte Counts in Peripheral Blood and Buffy Coat Collected During Extracorporeal Photopheresis
    Liu C, Shah K, Dynis M, Eby CS, Grossman BJ
    Transfusion 2013 Nov;53(11):2635-43
  • Genetics Informatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT): Rationale and Study Design
    Do EJ, Lenzini P, Eby CS, Bass AR, McMillin GA, Stevens SM, Woller SC, Pendleton RC, Anderson JL, Proctor P, Nunley RM, Davila-Roman V, Gage BF
    Pharmacogenomics J 2012 Oct;12(5):417-24
  • Warfarin Pharmacogenetics: Does More Accurate Dosing Benefit Patients?
    Eby C
    Semin Thromb Hemost 2012 Oct;38(7):661-6
  • External Quality Assurance of Fibrinogen Assays Using Normal Plasma: Results of the 2008 College of American Pathologists Proficiency Testing Program in Coagulation
    Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD
    Arch Pathol Lab Med 2012 Jul;136(7):789-95
  • Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors After One Week of Therapy
    Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, Caldwell MD, Eby CS, Rane A, Lindh JD, Shin JG, Kim HS, Angchaisuksiri P, Glynn RJ, Kronquist KE, Carlquist JF, Grice GR, Barrack RL, Li J, Gage BF
    Thromb Haemost 2012 Feb 2;107(2):232-40
  • The Occurrence of Antibodies to Heparin-Platelet Factor 4 in Cardiac and Thoracic Surgical Patients Receiving Desirudin or Heparin for Postoperative Venous Thrombosis Prophylaxis
    Avidan MS, Smith JR, Skrupky LP, Hill L, Jacobsohn E, Burnside B, Tymkew H, Eby C, Damiano R, Despotis GJ
    Thromb Res 2011 Dec;128(6):524-9
  • Venous Thromboembolic Disease
    Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A
    J Natl Compr Canc Netw 2011 Jul 1;9(7):714-77
  • External Quality Assurance of Antithrombin, Protein C, and Protein S Assays: Results of the College of American Pathologists Proficiency Testing Program in Thrombophilia
    Cunningham MT, Olson JD, Chandler WL, Van Cott EM, Eby CS, Teruya J, Hollensead SC, Adcock DM, Allison PM, Kottke-Marchant KK, Smith MD
    Arch Pathol Lab Med 2011 Feb;135(2):227-32
  • Intra-Individual Variability in Serum Hepcidin Precludes Its Use as a Marker of Iron Status in Hemodialysis Patients
    Ford BA, Eby CS, Scott MG, Coyne DW
    Kidney Int 2010 Oct;78(8):769-73
  • Blast Flagging With the UniCel(R) DxH 800 Coulter(R) Cellular Analysis System
    Barnes PW, Eby CS, Shimer G
    Lab Hematol 2010 Jun 1;16(2):23-5
  • Heparin and Oversulfated Heparin Byproduct Induce Thrombin Generation Through Contact System Activation in Plasma of Patients With HIT
    Qian Y, Pan J, Zhou X, Weiser P, Lu H, Shih FF, Porche-Sorbet R, Eby C, Zhang L
    Clin Appl Thromb Hemost 2010 Jun;16(3):251-60
  • Gamma-Glutamyl Carboxylase and Its Influence on Warfarin Dose
    King CR, Deych E, Milligan P, Eby C, Lenzini P, Grice G, Porche-Sorbet RM, Ridker PM, Gage BF
    Thromb Haemost 2010 Oct 1;104(4):750-4
  • Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing
    Lenzini P, Wadelius M, Kimmel S, Anderson JL, Jorgensen AL, Pirmohamed M, Caldwell MD, Limdi N, Burmester JK, Dowd MB, Angchaisuksiri P, Bass AR, Chen J, Eriksson N, Rane A, Lindh JD, Carlquist JF, Horne BD, Grice G, Milligan PE, Eby C, Shin J, Kim H, Kurnik D, Stein CM, McMillin G, Pendleton RC, Berg RL, Deloukas P, Gage BF
    Clin Pharmacol Ther 2010 May;87(5):572-8
  • A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
    Voora D, Koboldt DC, King CR, Lenzini PA, Eby CS, Porche-Sorbet R, Deych E, Crankshaw M, Milligan PE, McLeod HL, Patel SR, Cavallari LH, Ridker PM, Grice GR, Miller RD, Gage BF
    Clin Pharmacol Ther 2010 Apr;87(4):445-51
  • Ability of VKORC1 and CYP2C9 to Predict Therapeutic Warfarin Dose During the Initial Weeks of Therapy
    Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF
    J Thromb Haemost 2010 Jan;8(1):95-100
  • Safety Concerns Related to Use of Unapproved Needles for Accessing Implantable Venous Access Devices
    Powers ML, Lublin D, Eby C, Leitman SF, Dynis M, Despotis GJ
    Transfusion 2009 Sep;49(9):2008-9
  • Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy
    Linder MW, Bon Homme M, Reynolds KK, Gage BF, Eby C, Silvestrov N, Valdes R Jr
    Clin Chem 2009 Oct;55(10):1861-8
  • Antiphospholipid Syndrome Review
    Eby C
    Clin Lab Med 2009 Jun;29(2):305-19
  • Prediction and Management of Bleeding in Cardiac Surgery
    Despotis G, Avidan M, Eby C
    J Thromb Haemost 2009 Jul;7 Suppl 1:111-7
  • Counterpoint: Pharmacogenetic-Based Initial Dosing of Warfarin: Not Ready for Prime Time
    Eby CS
    Clin Chem 2009 Apr;55(4):712-4
  • Pathogenesis and Management of Bleeding and Thrombosis in Plasma Cell Dyscrasias
    Eby C
    Br J Haematol 2009 Apr;145(2):151-63
  • Variability of Ferritin Measurements in Chronic Kidney Disease; Implications for Iron Management
    Ford BA, Coyne DW, Eby CS, Scott MG
    Kidney Int 2009 Jan;75(1):104-10
  • Laboratory and Clinical Outcomes of Pharmacogenetic Vs. Clinical Protocols for Warfarin Initiation in Orthopedic Patients
    Lenzini PA, Grice GR, Milligan PE, Dowd MB, Subherwal S, Deych E, Eby CS, King CR, Porche-Sorbet RM, Murphy CV, Marchand R, Millican EA, Barrack RL, Clohisy JC, Kronquist K, Gatchel SK, Gage BF
    J Thromb Haemost 2008 Oct;6(10):1655-62
  • A Review of Transfusion Risks and Optimal Management of Perioperative Bleeding With Cardiac Surgery
    Despotis G, Eby C, Lublin DM
    Transfusion 2008 Mar;48(1 Suppl):2S-30S
  • Varicella Fulminant Hepatitis in an Adult Patient With Factor V Leiden Mutation and Trisomy 8 Related Myelodysplastic Syndrome
    Cattano D, Vannucci A, Nicolini A, Nania C, Buzzigoli S, Eby C
    J Clin Virol 2008 Sep;43(1):134-5
  • Lamellar Body Counts Performed on Automated Hematology Analyzers to Assess Fetal Lung Maturity
    Li J, Gronowski AM, Eby CS
    Lab Medicine 2008;39:419-24
  • Evaluation of a Prolonged Prothrombin Time
    Hood JL, Eby CS
    Clin Chem 2008 Apr;54(4):765-8
  • CYP4F2 Genetic Variant Alters Required Warfarin Dose
    Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK
    Blood 2008 Apr 15;111(8):4106-12
  • Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
    Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL
    Clin Pharmacol Ther 2008 Sep;84(3):326-31
  • Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose
    King CR, Porche-Sorbet RM, Gage BF, Ridker PM, Renaud Y, Phillips MS, Eby C
    Am J Clin Pathol 2008 Jun;129(6):876-83
  • Pharmacogenetic Dose Refinement Prevents Warfarin Overdose in a Patient Who Is Highly Warfarin-Sensitive
    Grice GR, Milligan PE, Eby C, Gage BF
    J Thromb Haemost 2008 Jan;6(1):207-9
  • Bleeding and Thrombosis Risks in Plasma Cell Dyscrasias
    Eby CS
    Hematology Am Soc Hematol Educ Program 2007;2007:158-64
  • Quality Assurance in Hemostasis: The Perspective From the College of American Pathologists Proficiency Testing Program
    Cunningham MT, Brandt JT, Chandler WL, Eby CS, Hayes TE, Krishnan J, Lefkowitz JB, Olson JD, Stasik CJ, Teruya J, Van Cott EM
    Semin Thromb Hemost 2007 Apr;33(3):250-8
  • Optimal Initial Dose Adjustment of Warfarin in Orthopedic Patients
    Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF
    Ann Pharmacother 2007 Nov;41(11):1798-804
  • Genetic-Based Dosing in Orthopedic Patients Beginning Warfarin Therapy
    Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF
    Blood 2007 Sep 1;110(5):1511-5
  • Use of Recombinant Factor VIIa for Hip Surgery in a Patient With Factor-VII Deficiency. A Case Report
    Gopalan PK, Clohisy JC, Cashen AF, Eby CS
    J Bone Joint Surg Am 2007 Feb;89(2):389-91
  • External Peer Review Quality Assurance Testing in Von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program
    Hayes TE, Brandt JT, Chandler WL, Eby CS, Kottke-Marchant K, Krishnan J, Lefkowitz JB, Olson JD, Rund CR, Van Cott EM, Cunningham MT
    Semin Thromb Hemost 2006 Jul;32(5):499-504
  • Loss of Factor VIII and Von Willebrand Factor Activities During Cold Storage of Whole Blood Is Reversed by Rewarming
    Refaai MA, Van Cott EM, Lukoszyk M, Hughes J, Eby CS
    Lab Hematol 2006;12(2):99-102
  • Clotting Profiles and Selected Hematology of Captive Speke's Gazelles (Gazella Spekei)
    Travis EK, Eby C
    J Zoo Wildl Med 2006 Mar;37(1):64-7
  • Population Variation in VKORC1 Haplotype Structure
    Marsh S, King CR, Porche-Sorbet RM, Scott-Horton TJ, Eby CS
    J Thromb Haemost 2006 Feb;4(2):473-4
  • Ischemia-Modified Albumin Increases After Skeletal Muscle Ischemia During Arthroscopic Knee Surgery
    Refaai MA, Wright RW, Parvin CA, Gronowski AM, Scott MG, Eby CS
    Clin Chim Acta 2006 Apr;366(1-2):264-8
  • Cold-Dependent Loss of Factor VIII Von Willebrand Factor Activities in Citrated Whole Blood Is Reversed by Rewarming
    Refaai MA, Lukoszyk M, Hughes J, Eby CS, Van Cott EM
    Am J Clin Pathol 2005 Dec;124(6):972; author reply 973
  • Soluble CD40 Ligand Measurement Inaccuracies Attributable to Specimen Type, Processing Time, and ELISA Method
    Halldorsdottir AM, Stoker J, Porche-Sorbet R, Eby CS
    Clin Chem 2005 Jun;51(6):1054-7
  • Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
    Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE
    N Engl J Med 2005 Jun 2;352(22):2285-93
  • Laboratory Assessment of Oxygenation in Methemoglobinemia
    Haymond S, Cariappa R, Eby CS, Scott MG
    Clin Chem 2005 Feb;51(2):434-44
  • Prospective Dosing of Warfarin Based on Cytochrome P-450 2C9 Genotype
    Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF
    Thromb Haemost 2005 Apr;93(4):700-5
  • The Pharmacogenetics of Coumarin Therapy
    Voora D, McLeod HL, Eby C, Gage BF
    Pharmacogenomics 2005 Jul;6(5):503-13
  • Recombinant Activated Factor VII for Non-Hemophiliac Bleeding Patients
    Uhlmann EJ, Eby CS
    Curr Opin Hematol 2004 May;11(3):198-204
  • An Evaluation of the Utility of Performing Body Fluid Counts on the Coulter LH 750
    Barnes PW, Eby CS, Shimer G
    Lab Hematol 2004;10(3):127-31
  • Transfusion Medicine Service Policies for Recombinant Factor VIIa Administration
    Goodnough LT, Lublin DM, Zhang L, Despotis G, Eby C
    Transfusion 2004 Sep;44(9):1325-31
  • The Genetics of Vitamin K Antagonists
    Gage BF, Eby CS
    Pharmacogenomics J 2004;4(4):224-5
  • Use of Pharmacogenetics to Guide Warfarin Therapy
    Voora D, McLeod HL, Eby C, Gage BF
    Drugs Today (Barc) 2004 Mar;40(3):247-57
  • Use of Pharmacogenetics and Clinical Factors to Predict the Maintenance Dose of Warfarin
    Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL
    Thromb Haemost 2004 Jan;91(1):87-94
  • Pharmacogenetics and Anticoagulant Therapy
    Gage BF, Eby CS
    J Thromb Thrombolysis 2003 Aug-Oct;16(1-2):73-8
  • Hemostatic Complications Associated With Paraproteinemias
    Eby C, Blinder M
    Curr Hematol Rep 2003 Sep;2(5):388-94
  • Lamellar Body Count in Amniotic Fluid: A Comparative Study of Four Different Hematology Analyzers
    Szallasi A, Gronowski AM, Eby CS
    Clin Chem 2003 Jun;49(6 Pt 1):994-7
  • Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ
    N Engl J Med 2003 Apr 10;348(15):1425-34
  • Residual Platelet Counts in Plasma Prepared for Routine Coagulation Testing With the Beckman Coulter Power Processor
    Barnes PW, Eby CS, Lukoszyk M
    Laboratory Hematology 2002;8:205-209
  • Prothrombotic States in Ischemic Stroke
    Eby CS
    Seminars in Cerebrovascular Diseases and Stroke 2002;2:90-101
  • Massive Retroperitoneal Pseudotumour in a Patient With Type 3 Von Willebrand Disease
    Eby CS, Caracioni AA, Badar S, Joist JH
    Haemophilia 2002 Mar;8(2):136-41
  • Laryngeal Epidermolysis Bullosa Acquisita Requiring Tracheostomy Presenting With an Acquired Factor VIII Coagulopathy
    Hurley D, Boyd JH, Eby C
    Otolaryngol Head Neck Surg 2001 Sep;125(3):270-1
  • Postpartum Coronary Artery Dissection Complicated by Heparin-Induced Thrombocytopenia and Thrombosis
    Eby CS, McBride LR
    Ann Thorac Surg 2001 Mar;71(3):1025-7
  • Pancytopenia After Removal of Copper From Total Parenteral Nutrition
    Fuhrman MP, Herrmann V, Masidonski P, Eby C
    JPEN J Parenter Enteral Nutr 2000 Nov-Dec;24(6):361-6
  • Heparin Induced Thrombocytopenia
    Eby CS
    Clin Lab Sci 1999 Nov-Dec;12(6):365-9
  • Accurate Monitoring of Heparin Therapy: A Team Approach
    Eby CS
    Advance/Laboratory 1999;8:100-106
  • Standardization of APTT Reagents for Heparin Therapy Monitoring: Urgent or Fading Priority?
    Eby C
    Clin Chem 1997 Jul;43(7):1105-7
  • Eosinophil Count Discrepancy Among Sysmex NE-8000 Automated Hematology Analyzer, Manual Method, and Other Analyzers in a Case of Chronic Eosinophilic Leukemia
    Polski JM, Dunphy CH, Pincus SM, Eby CS
    Lab Hematol 1997;3:305-310
  • Fatal Outcome in a Patient With Autoimmune Hemolytic Anemia Associated With an IgM Bithermic Anti-ITP
    Ramos RR, Curtis BR, Eby CS, Ratkin GA, Chaplin H
    Transfusion 1994 May;34(5):427-31
  • A Review of the Hypercoagulable State
    Eby CS
    Hematol Oncol Clin North Am 1993 Dec;7(6):1121-42
  • Warfarin-Induced Skin Necrosis
    Eby CS
    Hematol Oncol Clin North Am 1993 Dec;7(6):1291-300
  • Humoral Hypercalcemia in Seminomas
    da Silva MA, Edmondson JW, Eby C, Loehrer PJ Sr
    Med Pediatr Oncol 1992;20(1):38-41
  • Refractory Immune Hemolytic Anemia With a High Thermal Amplitude, Low Affinity IgG Anti-Pra Cold Autoantibody
    Ramos RR, Curtis BR, Sadler JE, Eby CS, Chaplin H
    Autoimmunity 1992;12(2):149-54

Book Chapters

  • Bleeding Associated with Disseminated Intravascular Coagulation
    Eby C
    In: Teruya J (ed), Management of Bleeding Patients. Springer, Cham. 2016; pp 139-143
  • Bleeding Associated with Coagulation Factor Inhibitors
    Eby C
    In: Teruya J (ed), Management of Bleeding Patients. Springer, Cham. 2016; pp 85-92
  • Laboratory, Transfusion Medicine, and Pathology Services
    Eby CS
    In: The Washington Manual of Patient Safety and Quality Improvement. Wolters Kluwer, 2016
  • Antiphospholipid Antibodies
    Van Cott B, Eby CE
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, 2nd edition. CAP Press, 2016
  • Laboratory Diagnosis of Inherited Thrombophilias
    Eby CS
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, 2nd edition. CAP Press, 2016
  • Thrombophilia Testing
    Eby CS
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, 2nd edition. CAP Press, 2016
  • Laboratory Hematology
    Eby CS, Frater JL, Rand JH
    In: American Society of HematologySelf-Assessment Program (ASH-SAP) 5th edition, 2013
  • Disorders of Hemostasis
    Yusen RD, Eby CS, Sanfillipo K, Gage B
    In: The Washington Manual of Medical Therapeutics, 34th edition, Lippincott Williams & Wilkins, Philadelphia, 2013
  • Hemostatic Challenges in Liver Disease; Chapter 126
    Eby CS, Caldwell SH
    In: Marder VJ, Aird WC, Bennett J, Schulman S, White GC III (eds), Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 6th edition, 2012
  • Laboratory Hematology
    Dent G, Eby CS
    In: American Society of HematologySelf-Assessment Program (ASH-SAP) 4th edition, 2010
  • Disorders of Hemostasis
    Yusen RD, Eby CS, Gage B
    In: The Washington Manual of Medical Therapeutics, 33rd edition, Lippincott Williams & Wilkins, Philadelphia, 2010
  • Antiphospholipid Antibodies
    Van Cott B, Eby CS
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, CAP Press, 2008
  • Laboratory Diagnosis of Inherited Thrombophilias
    Eby CS
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, CAP Press, 2008
  • Thrombophilia Testing
    Eby CS
    In: Kottke-Marchant K, An Algorthimic Approach to Hemostasis Testing, CAP Press, 2008
  • Thrombosis and Cancer
    Eby CS
    In: Govindan R (ed), The Washington Manual of Oncology, 2nd edition, Lippincott Williams & Wilkins, Philadelphia, 2008
  • Disorders of Hemostasis
    Walgren R, Yusen RD, Eby CS
    In: The Washington Manual of Medical Therapeutics, 32nd edition, Lippincott Williams & Wilkins, Philadelphia, 2007
  • A Reference Range Outlier
    Eby CS
    In: Scott MG, Gronowski AM, Eby CS (eds), Tietz's Applied Laboratory Medicine, 2nd Edition, John Hiley and Sons, Hoboken, NJ, 2007
  • Hemostatic Complications in Liver Disease
    Eby CS, Joist JH
    In: Colman RW, Hirsh J, Clowes AW, George JN, Marder VJ (eds), Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th edition, 2005
  • Point-Of Care Testing in the Operating Room
    Refaai MA, Despotis GJ, Eby C, Scott MG
    In: Price CP, St John A, Hicks, JM (eds) Point-of-care testing, 2nd edition, AACC Press, Washington, DC, 2004
  • Hematology and Hemostasis During Pregnancy
    Eby CS
    In: Gronowski AM (ed), Current Clinical Pathology: Handbook of Clinical Laboratory Testing During Pregnancy, Humana Press, Totowa, NJ, 2004
  • Disorders of Hemostasis
    Andritsos L, Yusen RD, Eby CS
    In: The Washington Manual of Medical Therapeutics, 31st edition, Lippincott Williams & Wilkins, Philadelphia, 2004; pp 398-422
  • Disorders of Platelets and Primary Hemostasis
    Laffely, NH, Andritsos L, Eby CS
    In: Pillot G (ed), Washington Manual Hematology and Oncology Subspecialty Consult, Lippincott Williams & Wilkins, Philadelphia, 2004; pp 49-60
  • Myelodysplasia and Myeloproliferative Disorders
    Eby CS, Adkins D
    In: Govindan R (ed), The Washington Manual of Oncology, Lippincott Williams & Wilkins, Philadelphia, 2002; pp 310-324
  • Laboratory Evaluation of Hemostatic Disorders
    Santoro SA, Eby CS
    In: Hoffman R, et al (eds), Hematology-Basic Principles and Practice, 3rd Edition, Churchill Livingstone, New York, 2000; pp 1841-1850
  • Complications of Cirrhosis: Hemostatic Failure
    Joist JH, Eby CS
    In: Bacon B, DiBisceglie A (eds), Liver Disease: Diagnosis and Management, WB Saunders Company, Philadelphia, PA, 1999
  • Laboratory Evaluation of Hemostatic Disorders
    Santoro SA, Eby CS
    In: Hoffman R, et al (eds), Hematology-Basic Principles and Practice, 2nd Edition, Churchill Livingstone, New York, 1995; pp 1622-1632

Textbook Editing

  • An Algorthimic Approach to Hemostasis Testing
    Eby C, section editor
    CAP Press, 2008
  • Tietz's Applied Laboratory Medicine, 2nd Edition
    Scott MG, Gronowski AM, Eby CS, editors
    John Wiley and Sons, Hoboken, NJ, 2007